What Analysts say About Genworth Financial Inc (GNW) and Immunomedics Inc (IMMU)

Marco Green
September 30, 2017

Valero Energy Corporation (NYSE:VLO) closed at $75.47 a share in the latest session and the stock value rose nearly 10.47% since the beginning of this year. It has underperformed by 82.30% the S&P500.

Genworth Financial Inc (NYSE:GNW)'s shares climbed 2.64% in the past week and soared 13.41% in the last 4 weeks, historically the stock illustrate that its six months performance stands at -5.35% while its year to date performance is at 2.1%. MTOR's profit will be $39.85M for 14.56 P/E if the $0.45 EPS becomes a reality. The company's revenue for the quarter was down.6% on a year-over-year basis. About 299,665 shares traded. (NYSE:GNW) advice adding it to buy candidate list. (NYSE:GNW) stock volatility was recorded 4.55% which for the previous full month was noted 3.88%. Therefore 13% are positive. Shares are trading at $3.89 which is slightly above the 50 day moving average which is $3.55 and which is just a bit higher than the 200 day moving average of $3.72. Genworth Financial Inc (NYSE:GNW)'s price sits 9.32% above from its 50-day moving average of $3.61 and 3.58% far from the stock's 200-day moving average which is $3.71. BTIG Research reissued a "neutral" rating on shares of Genworth Financial in a report on Saturday, September 16th. UBS downgraded the shares of GNW in report on Wednesday, November 4 to "Sell" rating. (NYSE:GNW) is performing 2.1%. The firm has "Neutral" rating given on Wednesday, August 5 by Macquarie Research.

01/13/2016 - Genworth Financial Inc had its "neutral" rating reiterated by analysts at Goldman Sachs. The company was maintained on Monday, February 8 by Compass Point. It tells an investor how quickly a company is increasing its revenues. Its up 0.05, from 1.07 in 2017Q1. 33 funds opened positions while 77 raised stakes. Northwestern Mutual Investment Management Company, LLC reduced its investment by selling 8 shares a decrease of 0.0% from 03/31/2017 to 06/30/2017. Genworth Financial, Inc. (NYSE:GNW) for the trailing twelve months paying dividend with the payout ratio of 0.00% to its shareholders. Raymond James Financial Services Advisors Inc. increased its stake in shares of Genworth Financial by 29.5% in the 1st quarter. Tiaa Cref Inv Mngmt Ltd Liability reported 1.74 million shares. The count of Hold ratings in that period was 0. ValuEngine upgraded Genworth Financial from a "sell" rating to a "hold" rating in a research report on Friday, September 1st.

01/08/2015 - Bank of America Merrill Lynch began new coverage on Genworth Financial Inc giving the company a "underweight" rating. Genworth Financial earned a media sentiment score of 0.25 on Accern's scale. Alliancebernstein L P stated it has 0% in Genworth Financial Inc (NYSE:GNW). State Treasurer State Of Michigan holds 0.01% in Genworth Financial Inc (NYSE:GNW) or 205,650 shares.

The company is now up by 0.26% percent from yesterday's close.

In terms of Buy/Sell recommendations, 4 analysts have a consensus rating of 2.5 on the shares of Genworth Financial Inc (NYSE:GNW).

Genworth Financial, Inc. provides mortgage insurance products that allow people to purchase homes. Stocks with a beta above 1 tend to have bigger swings in price than the market as a whole, the opposite being the case for stocks with a beta below 1. However, it, too, needs to be taken into the context of a company's peer group as well as its sector. It now has negative earnings. Its segments include U.S. Mortgage Insurance, Canada Mortgage Insurance, Australia Mortgage Insurance, U.S. Life Insurance, Runoff, and Corporate and Other.

Cytori Therapeutics, Inc.is a biotechnology firm engaged in the development of treatments and devices for a range of disorders using cells as a key part of the therapy.

In the last earnings report the EPS was $-0.29 and is estimated to be $1.03 for the current year with 499,143,000 shares now outstanding. Therefore 60% are positive. The stock saw a fall in short interest of -2.17% as of August 31, 2017 from the last reporting period. The stock has "Hold" rating by Zacks on Friday, September 4.

10/31/2013 - Genworth Financial Inc had its "buy" rating reiterated by analysts at Sandler O'Neill.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER